Cargando…
Adhatoda Vasica attenuates inflammatory and hypoxic responses in preclinical mouse models: potential for repurposing in COVID-19-like conditions
BACKGROUND: COVID-19 pneumonia has been associated with severe acute hypoxia, sepsis-like states, thrombosis and chronic sequelae including persisting hypoxia and fibrosis. The molecular hypoxia response pathway has been associated with such pathologies and our recent observations on anti-hypoxic an...
Autores principales: | Gheware, Atish, Dholakia, Dhwani, Kannan, Sadasivam, Panda, Lipsa, Rani, Ritu, Pattnaik, Bijay Ranjan, Jain, Vaibhav, Parekh, Yash, Enayathullah, M. Ghalib, Bokara, Kiran Kumar, Subramanian, Venkatesan, Mukerji, Mitali, Agrawal, Anurag, Prasher, Bhavana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8022127/ https://www.ncbi.nlm.nih.gov/pubmed/33823870 http://dx.doi.org/10.1186/s12931-021-01698-9 |
Ejemplares similares
-
Adhatoda Vasica
Publicado: (1893) -
Anti-SARS-CoV-2 potential of Cissampelos pareira L. identified by connectivity map-based analysis and in vitro studies
por: Haider, Madiha, et al.
Publicado: (2022) -
Combined genetic effects of EGLN1 and VWF modulate thrombotic outcome in hypoxia revealed by Ayurgenomics approach
por: Aggarwal, Shilpi, et al.
Publicado: (2015) -
Potential Uses of Adhatoda Vasica in Orthodontics
por: Subramanian, Murukesan, et al.
Publicado: (2023) -
A Preliminary Note on the Pharmacology and Therapeutics of Adhatoda Vasica (Basak)
por: Chopra, R. N., et al.
Publicado: (1925)